drugset / Trial / NCT00779558

Heparin and the Reduction of Thrombosis (HART) Trial

NCT00779558

Completed 90 enrolled Stanford University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Timeline

Start
2005-11
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 10 iu/kg

Indications